INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,750,350 | -39.1% | 861,400 | -49.1% | 0.16% | -10.6% |
| Q2 2023 | $35,687,464 | +23.8% | 1,691,349 | 0.0% | 0.18% | -3.7% |
| Q1 2023 | $28,837,500 | -6.4% | 1,691,349 | +9.7% | 0.19% | -23.7% |
| Q4 2022 | $30,796,153 | +2.8% | 1,541,349 | +10.8% | 0.24% | +28.3% |
| Q3 2022 | $29,970,000 | +140.5% | 1,391,349 | +120.2% | 0.19% | +161.6% |
| Q2 2022 | $12,460,000 | -16.1% | 631,849 | 0.0% | 0.07% | +9.0% |
| Q1 2022 | $14,848,000 | -69.7% | 631,849 | -64.9% | 0.07% | -63.6% |
| Q4 2021 | $48,983,000 | -1.1% | 1,798,209 | 0.0% | 0.18% | -8.9% |
| Q3 2021 | $49,523,000 | +85.8% | 1,798,209 | +92.0% | 0.20% | +74.1% |
| Q2 2021 | $26,651,000 | -16.4% | 936,438 | 0.0% | 0.12% | -41.1% |
| Q1 2021 | $31,895,000 | +36.6% | 936,438 | +33.5% | 0.20% | +39.7% |
| Q4 2020 | $23,346,000 | – | 701,301 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |